236 related articles for article (PubMed ID: 26516370)
1. Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.
Stein-Merlob AF; Kessinger CW; Erdem SS; Zelada H; Hilderbrand SA; Lin CP; Tearney GJ; Jaff MR; Reed GL; Henke PK; McCarthy JR; Jaffer FA
Theranostics; 2015; 5(12):1317-27. PubMed ID: 26516370
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
McCarthy JR; Sazonova IY; Erdem SS; Hara T; Thompson BD; Patel P; Botnaru I; Lin CP; Reed GL; Weissleder R; Jaffer FA
Nanomedicine (Lond); 2012 Jul; 7(7):1017-28. PubMed ID: 22348271
[TBL] [Abstract][Full Text] [Related]
4. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent ultrastructural changes during venous thrombogenesis and thrombus resolution.
Chernysh IN; Mukhopadhyay S; Johnson TA; Brooks JA; Sarkar R; Weisel JW; Antalis TM
J Thromb Haemost; 2024 Jun; 22(6):1675-1688. PubMed ID: 38492853
[TBL] [Abstract][Full Text] [Related]
6. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
7. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model.
Chessum JE; Shaya SA; Rajab D; Aftabjahani A; Zhou J; Weitz JI; Gross PL; Kim PY
J Thromb Haemost; 2024 Jan; 22(1):263-270. PubMed ID: 37751849
[TBL] [Abstract][Full Text] [Related]
10. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.
Andia ME; Saha P; Jenkins J; Modarai B; Wiethoff AJ; Phinikaridou A; Grover SP; Patel AS; Schaeffter T; Smith A; Botnar RM
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1193-1198. PubMed ID: 24723557
[TBL] [Abstract][Full Text] [Related]
11. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
[TBL] [Abstract][Full Text] [Related]
12. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring.
Kessinger CW; Kim JW; Henke PK; Thompson B; McCarthy JR; Hara T; Sillesen M; Margey RJ; Libby P; Weissleder R; Lin CP; Jaffer FA
PLoS One; 2015; 10(2):e0116621. PubMed ID: 25680183
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and Inflammation in Venous Thrombus Resolution.
Mukhopadhyay S; Johnson TA; Duru N; Buzza MS; Pawar NR; Sarkar R; Antalis TM
Front Immunol; 2019; 10():1348. PubMed ID: 31258531
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
[TBL] [Abstract][Full Text] [Related]
15. Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Kattula S; Sang Y; de Ridder G; Silver AC; Bouck EG; Cooley BC; Wolberg AS
J Thromb Haemost; 2021 Dec; 19(12):2997-3007. PubMed ID: 34431201
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
17. Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli.
Kim DE; Kim JY; Lee SK; Ryu JH; Kwon IC; Ahn CH; Kim K; Schellingerhout D
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768026
[TBL] [Abstract][Full Text] [Related]
18. Alterations in macrophage phenotypes in experimental venous thrombosis.
Gallagher KA; Obi AT; Elfline MA; Hogikyan E; Luke CE; Henke S; Coleman D; Henke PK
J Vasc Surg Venous Lymphat Disord; 2016 Oct; 4(4):463-71. PubMed ID: 27639001
[TBL] [Abstract][Full Text] [Related]
19. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.
Kanji R; Kubica J; Navarese EP; Gorog DA
Eur J Clin Invest; 2021 Apr; 51(4):e13471. PubMed ID: 33296082
[TBL] [Abstract][Full Text] [Related]
20. In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.
Ay I; Blasi F; Rietz TA; Rotile NJ; Kura S; Brownell AL; Day H; Oliveira BL; Looby RJ; Caravan P
Circ Cardiovasc Imaging; 2014 Jul; 7(4):697-705. PubMed ID: 24777937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
